ME
MetLife
MET · NYSE
$97.61 -1.63% (-$1.62)
1M +0.61%
Market Cap $62.8B
P/E Ratio 17.32x
Div. Yield 2.35%
ROE 12.95%
Bulios Fair Price
$114.21
17.0% upside
Current Price
$97.61
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MET is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
61 /100
Fair P/E 17.32x
P/S 0.80x
P/B 2.30x
Growth
18 /100
Declining EPS growth 8.67%
Rev. growth 4.29%
Book val. growth 1.68%
Profitability
14 /100
Weak Net margin 4.61%
Op. margin 6.19%
Gross margin N/A
Quality
65 /100
Average ROE 12.95%
ROA 0.48%
Asset turnover 0.11x
Debt
100 /100
Low Current ratio 453.01x
Debt/Equity N/A
Int. coverage N/A
Stability
68 /100
Stable Beta 0.76x
Rev. volatility 5.38%
EPS volatility 159.99%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MET
Online
Sector
Financial Services
Industry
Insurance - Life
CEO
Michel Abbas Khalaf
Employees
46,000
Headquarters
New York City
Upcoming events
04 NOV
Earnings
Upcoming earnings report